Back to BLAIR WILLIAM & CO/IL BLAIR WILLIAM & CO/IL

IKTIKT
13 quarters

Position history for BLAIR WILLIAM & CO/ILBLAIR WILLIAM & CO/IL's holdings in INHIBIKASE THERAPEUTICS INC

BLAIR WILLIAM & CO/IL holds 156,080 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $316,842 as of 2026-Q2. The position was decreased (-1.2% shares). IKT represents 0.0% of BLAIR WILLIAM & CO/IL's portfolio.

Current Value

$316,842

Current Shares

156,080

Total Value Change

+$107,866

Total Shares Change

+98,192

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
156,080
-1.2%
$316,8420.0%$2.03
0
2026-Q1
Increased
157,988
+3.3%
$265,4200.0%$1.91
24
2025-Q4
Unchanged
152,953
0.0%
$313,5540.0%$1.97
0
2025-Q3
Decreased
152,953
-2.5%
$247,7840.0%$1.53
0
2025-Q2
Increased
156,953
+0.6%
$306,0580.0%$1.62
24
2025-Q1
Increased
155,953
+15.6%
$341,5370.0%$2.29
27
2024-Q4
Increased
134,953
+7.0%
$438,5970.0%$3.24
26
2024-Q3
Increased
126,120
+8.6%
$163,9560.0%$1.17
24
2024-Q2
Increased
116,120
+51.6%
$140,5050.0%$1.21
31
2024-Q1
Increased
76,601
+27.1%
$165,4580.0%$2.16
28
2023-Q4
Increased
60,268
+1.5%
$76,5400.0%$1.27
22
2023-Q3
Increased
59,375
+2.6%
$82,5310.0%$1.39
22
2023-Q2
New
57,888
-
$208,9760.0%$3.66
32

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used